Mass spectrometry-based quantitative analysis and biomarker discovery.

  • Naoto Suzuki
  • Published 2011 in
    Yakugaku zasshi : Journal of the Pharmaceutical…

Abstract

Mass spectrometry-based quantitative analysis and biomarker discovery using metabolomics approach represent one of the major platforms in clinical fields including for the prognosis or diagnosis, assessment of severity and response to therapy in a number of clinical disease states as well as therapeutic drug monitoring (TDM). This review first summarizes… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics